Kang, S.H.; Choi, J.; Yim, H.J.; Jung, Y.K.; Yim, S.Y.; Lee, Y.-S.; Seo, Y.S.; Kim, J.H.; Yeon, J.E.; Byun, K.S.
Association Between SGLT2 Inhibitor Use and Reduced Risk of Liver-Related Events, Including Hepatocellular Carcinoma, in Diabetic Patients with Viral Hepatitis: A Nationwide Cohort Study. Cancers 2026, 18, 120.
https://doi.org/10.3390/cancers18010120
AMA Style
Kang SH, Choi J, Yim HJ, Jung YK, Yim SY, Lee Y-S, Seo YS, Kim JH, Yeon JE, Byun KS.
Association Between SGLT2 Inhibitor Use and Reduced Risk of Liver-Related Events, Including Hepatocellular Carcinoma, in Diabetic Patients with Viral Hepatitis: A Nationwide Cohort Study. Cancers. 2026; 18(1):120.
https://doi.org/10.3390/cancers18010120
Chicago/Turabian Style
Kang, Seong Hee, Jimi Choi, Hyung Joon Yim, Young Kul Jung, Sun Young Yim, Young-Sun Lee, Yeon Seok Seo, Ji Hoon Kim, Jong Eun Yeon, and Kwan Soo Byun.
2026. "Association Between SGLT2 Inhibitor Use and Reduced Risk of Liver-Related Events, Including Hepatocellular Carcinoma, in Diabetic Patients with Viral Hepatitis: A Nationwide Cohort Study" Cancers 18, no. 1: 120.
https://doi.org/10.3390/cancers18010120
APA Style
Kang, S. H., Choi, J., Yim, H. J., Jung, Y. K., Yim, S. Y., Lee, Y.-S., Seo, Y. S., Kim, J. H., Yeon, J. E., & Byun, K. S.
(2026). Association Between SGLT2 Inhibitor Use and Reduced Risk of Liver-Related Events, Including Hepatocellular Carcinoma, in Diabetic Patients with Viral Hepatitis: A Nationwide Cohort Study. Cancers, 18(1), 120.
https://doi.org/10.3390/cancers18010120
